Nuvectis Pharma Inc (NVCT)
6.62
-0.05
(-0.75%)
USD |
NASDAQ |
May 23, 16:00
6.62
0.00 (0.00%)
After-Hours: 17:10
Nuvectis Pharma Total Liabilities (Quarterly): 5.692M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.692M |
| December 31, 2023 | 6.984M |
| September 30, 2023 | 5.576M |
| June 30, 2023 | 4.609M |
| March 31, 2023 | 3.934M |
| December 31, 2022 | 6.186M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.492M |
| June 30, 2022 | 2.738M |
| March 31, 2022 | 3.059M |
| December 31, 2021 | 17.66M |
| September 30, 2021 | 15.74M |
| June 30, 2021 | 11.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.738M
Minimum
Jun 2022
17.66M
Maximum
Dec 2021
7.358M
Average
5.634M
Median
Total Liabilities (Quarterly) Benchmarks
| Schrodinger Inc | 224.06M |
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.71M |
| Shareholders Equity (Quarterly) | 14.02M |